SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 21.031
EU - Europa 17.316
AS - Asia 14.141
SA - Sud America 3.137
AF - Africa 494
OC - Oceania 84
Continente sconosciuto - Info sul continente non disponibili 26
Totale 56.229
Nazione #
US - Stati Uniti d'America 20.666
PL - Polonia 5.848
CN - Cina 4.713
SG - Singapore 4.377
UA - Ucraina 3.594
BR - Brasile 2.648
IT - Italia 2.447
HK - Hong Kong 2.047
DE - Germania 1.420
FI - Finlandia 1.141
VN - Vietnam 1.083
FR - Francia 770
TR - Turchia 583
GB - Regno Unito 541
IE - Irlanda 495
RU - Federazione Russa 478
IN - India 268
NG - Nigeria 241
AR - Argentina 204
JP - Giappone 204
CA - Canada 179
BD - Bangladesh 170
NL - Olanda 168
ID - Indonesia 161
MX - Messico 122
IQ - Iraq 109
SE - Svezia 93
AU - Australia 82
EC - Ecuador 76
ZA - Sudafrica 74
PK - Pakistan 54
CO - Colombia 53
ES - Italia 51
AT - Austria 47
MA - Marocco 47
SA - Arabia Saudita 45
PY - Paraguay 42
CZ - Repubblica Ceca 41
UZ - Uzbekistan 35
VE - Venezuela 35
MY - Malesia 30
EG - Egitto 29
BE - Belgio 28
CL - Cile 27
JO - Giordania 26
PE - Perù 26
EU - Europa 25
IR - Iran 23
KE - Kenya 22
TW - Taiwan 22
CH - Svizzera 20
TN - Tunisia 19
AZ - Azerbaigian 17
KR - Corea 17
KZ - Kazakistan 17
LT - Lituania 17
AE - Emirati Arabi Uniti 16
AL - Albania 16
NP - Nepal 16
UY - Uruguay 15
IL - Israele 14
DZ - Algeria 13
LV - Lettonia 13
ET - Etiopia 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
RO - Romania 12
TH - Thailandia 12
PA - Panama 11
RS - Serbia 11
PT - Portogallo 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
PH - Filippine 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
CR - Costa Rica 8
MU - Mauritius 8
HU - Ungheria 7
JM - Giamaica 7
LB - Libano 7
OM - Oman 7
AM - Armenia 6
GR - Grecia 6
HN - Honduras 6
SN - Senegal 6
MK - Macedonia 5
BW - Botswana 4
BY - Bielorussia 4
GT - Guatemala 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NO - Norvegia 4
SV - El Salvador 4
UG - Uganda 4
BB - Barbados 3
BH - Bahrain 3
Totale 56.179
Città #
Warsaw 5.825
Jacksonville 2.272
Singapore 2.240
Fairfield 2.014
Hong Kong 2.013
Woodbridge 1.999
Ashburn 1.559
Houston 1.182
Princeton 970
The Dalles 951
Ann Arbor 928
Cambridge 871
Beijing 824
Wilmington 770
Seattle 749
Nanjing 739
San Jose 711
Helsinki 661
Dublin 488
Istanbul 460
Lauterbourg 431
Chandler 401
Los Angeles 376
New York 345
Ho Chi Minh City 322
Milan 312
Nanchang 296
Des Moines 240
Abuja 238
São Paulo 218
Dong Ket 216
Buffalo 208
Moscow 200
Council Bluffs 187
Changsha 185
Redondo Beach 185
Shenyang 178
Hebei 176
Brescia 168
Hanoi 158
Munich 131
Dearborn 127
San Diego 118
Tianjin 115
Shanghai 112
Dallas 111
Jiaxing 110
Hangzhou 99
Chicago 96
Rio de Janeiro 96
Rome 95
Jinan 90
Tokyo 83
Orem 82
San Francisco 82
Phoenix 79
Verona 78
Jakarta 74
Toronto 65
London 64
Nuremberg 64
Santa Clara 64
Kocaeli 60
Kunming 57
Guangzhou 52
Brooklyn 50
Montreal 50
Belo Horizonte 47
Atlanta 46
Chennai 46
Lanzhou 41
Baghdad 40
Brasília 40
Curitiba 39
Ningbo 38
Frankfurt am Main 37
Paris 37
Zhengzhou 36
Turku 35
Denver 34
Melbourne 34
Porto Alegre 34
Redwood City 34
Bologna 33
Campinas 31
Dhaka 31
Amsterdam 30
Brno 30
Mumbai 30
Norwalk 30
Tashkent 30
Haiphong 29
Palermo 28
San Mateo 28
Da Nang 27
Manchester 27
Stockholm 27
Amman 26
Johannesburg 26
Augusta 25
Totale 36.676
Nome #
The pathophysiology of IgA nephropathy 943
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 892
Genome-wide association study identifies susceptibility loci for IgA nephropathy 487
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 466
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 286
Genetic drivers of kidney defects in the digeorge syndrome 284
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 283
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 277
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 274
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 270
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 264
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 259
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 258
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 254
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 251
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 248
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 248
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 247
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 247
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 247
Mutations in DSTYK and dominant urinary tract malformations. 247
Defective intracellular trafficking of uromodulin mutant isoforms 244
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 244
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 243
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 241
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 240
Uromodulin storage diseases: clinical aspects and mechanisms. 238
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 235
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 234
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 234
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 233
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 232
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 232
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 230
Genetic studies of IgA nephropathy: past, present, and future. 229
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 227
Atheroembolic renal disease 226
IgA nephropathy--the case for a genetic basis becomes stronger. 224
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 223
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 223
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 220
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 217
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 216
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 216
Copy number disorders are a Common Cause of Congenital Kidney Malformations 216
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 215
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 215
Phenotypic expansion of DGKE-associated diseases. 215
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 213
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 212
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 211
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 207
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 205
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 195
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 194
The progression from obesity to type 2 diabetes in Alström syndrome. 193
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 192
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 189
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 188
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 185
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 180
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 179
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 179
Uromodulin: from monogenic to multifactorial diseases. 178
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 172
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 172
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 170
Berger's Disease 169
ORO-FACIO-DIGITAL SYNDROME 169
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 168
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 166
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 165
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 157
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 156
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 156
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 154
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 152
Non-collagen genes role in digenic Alport syndrome 151
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 148
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 145
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 142
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 141
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 141
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 140
Early histopathologic changes predicting long-term kidney transplant survival. 140
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 140
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 140
Immunogenetics of Henoch-Schoenlein disease. 140
[The role of magnetic resonance angiography in the assessment of arterial stenosis in the transplanted kidney] 140
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 139
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 138
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 138
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? 136
Atheroembolic renal disease. 136
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 135
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 135
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 134
[Hyperuricemia and Gout] 134
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 134
Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome 133
Totale 21.820
Categoria #
all - tutte 239.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.685 0 0 0 0 0 0 0 0 0 680 674 331
2021/20223.095 134 746 27 101 55 94 171 202 172 339 284 770
2022/20231.966 518 20 32 102 118 644 6 146 193 17 89 81
2023/20242.787 104 49 153 244 77 274 122 80 1.022 45 63 554
2024/20257.332 48 46 53 839 965 576 996 200 721 386 1.588 914
2025/202615.174 1.275 2.311 1.457 2.628 1.215 980 2.517 709 1.069 1.013 0 0
Totale 56.784